Thioredoxin-1 and endothelial cell aging: Role in cardiovascular diseases

Antioxidants and Redox Signaling

Volumn 11, Issue 7, 2009, Pages 1733-1740

  Altschmied, Joachim ^a   Haendeler, Judith ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; THIOREDOXIN 1;

CARDIOVASCULAR DISEASE; CELL AGING; CELL FUNCTION; CELL PROLIFERATION; DIABETES MELLITUS; ENDOTHELIUM CELL; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

CARDIOVASCULAR DISEASES; CELL AGING; ENDOTHELIUM, VASCULAR; HUMANS; THIOREDOXINS;

EID: 66749136902     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2379     Document Type: Review

References (77)

1. Ago T, Yeh I, Yamamoto M, Schinke-Braun M, Brown JA, Tian B, and Sadoshima J. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal 8: 1635-1650, 2006.
2. Aota M, Matsuda K, Isowa N, Wada H, Yodoi J, and Ban T. Protection against reperfusion-induced arrhythmias by human thioredoxin. J Cardiovasc Pharmacol 27: 727-732, 1996.
3. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 427-436, 2004.
4. Asai K, Kudej RK, Shen YT, Yang GP, Takagi G, Kidej AB, Geng YJ, Sato N, Nazareno JB, Vatner DE, Natividad F, Bishop SP, and Vatner SF. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol 20: 1493-1499, 2000.
5. Chou TC, Yen MH, Li CY, and Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643-648, 1998.
6. Chyu KY, Dimayuga PC, Zhao X, Nilsson J, Shah PK, and Cercek B. Altered AP-1/Ref-1 redox pathway and reduced proliferative response in iNOS-deficient vascular smooth muscle cells. Vasc Med 9: 177-183, 2004.
7. Das KC, Lewis-Molock Y, and White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 17: 713-726, 1997.
8. Dimmeler S, Fisslthaler B, Fleming I, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
9. Dimmeler S, Haendeler J, Rippmann V, Nehls M, and Zeiher AM. Shear stress inhibits apoptosis of human endothelial cells. FEBS Lett 399: 71-74, 1996.
10. Dimmeler S, Hermann C, Galle J, and Zeiher AM. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol 19: 656-664, 1999.
11. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
12. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
13. Gal A, Tamir S, Kennedy LJ, Tannenbaum SR, and Wogan GN. Nitrotyrosine formation, apoptosis and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumor. Cancer Res 57: 1823-1828, 1997.
14. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
15. Haendeler J, Hoffmann J, Diehl JF, Vasa M, Spyridopoulos I, Zeiher AM, and Dimmeler S. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 94: 768-775, 2004.
16. Haendeler J, Hoffmann J, Tischler V, Berk BC, Zeiher AM, and Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat Cell Biol 4: 743-749, 2002.
17. Haendeler J, Tischler V, Hoffmann J, Zeiher AM, and Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett 577: 427-433, 2004.
18. Harper R, Wu K, Chang MM, Yoneda K, Pan R, Reddy SP, and Wu R. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione. Am J Respir Cell Mol Biol 25: 178-185, 2001.
19. Hermann C, Zeiher AM, and Dimmeler S. Shear stress inhibits H2O2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase. Arterioscler Thromb Vasc Biol 17: 3588-3592, 1997.
20. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638, 1997.
21. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897, 1999.
22. Hoffmann J, Dimmeler S, and Haendeler J. Shear stress increases the amount of S-nitrosylated molecules in endothelial cells: Important role for signal transduction. FEBS Lett 551: 153-158, 2003.
23. Hoffmann J, Haendeler J, Aicher A, Rossig L, Vasa M, Zeiher AM, and Dimmeler S. Aging enhances the sensitivity of endothelial cells toward apoptotic stimuli: important role of nitric oxide. Circ Res 89: 709-715, 2001.
24. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
25. Holmgren A. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2: 811-820, 2000.
26. Jekell A, Hossain A, Alehagen U, Dahlstrom U, and Rosen A. Elevated circulating levels of thioredoxin and stress in chronic heart failure. Eur J Heart Fail 6: 883-890, 2004.
27. Kaga S, Zhan L, Matsumoto M, and Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39: 813-822, 2005.
28. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, and Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 65: 491-494, 2001.
29. Kuster GM, Pimentel DR, Adachi T, Ido Y, Brenner DA, Cohen RA, Liao R, Siwik SA, and Colucci WS. Alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes is mediated via thioredoxin-1-sensitive oxidative modification of thiols on Ras. Circulation 111: 1192-1198, 2005.
30. Li PF, Dietz R, and von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Lett 404: 249-252, 1997.
31. Liu Y and Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 90: 1259-1266, 2002.
32. Liu X, Pachori AS, Ward CA, Davis JP, Gnecchi M, Kong D, Zhang L, Murduck J, Yet SF, Perrella MA, Pratt RE, Dzau VJ, and Melo LG. Heme oxygenase-1 (HO-1) inhibits post-myocardial infarct remodeling and restores ventricular function. FASEB J 20: 207-216, 2006.
33. Liu X, Wei J, Peng DH, Layne MD, and Yet SF. Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice. Diabetes 54: 778-784, 2005.
34. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 1996; 178: 179-185, 1996.
35. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acque G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, and Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno- associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602-607, 2002.
36. Miyashiro JK, Poppa V, and Berk BC. Flow-induced vascular remodeling in the rat carotid artery diminishes with age. Circ Res 81: 311-319, 1997.
37. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem 270: 2109-2119, 2003.
38. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
39. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003
40. Nordberg J and Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31: 1287-1312, 2001.
41. Okuda M, Inoue N, Azumi H, Seno T, Sumi Y, Hirata KI, Kawashima S, Hayashi Y, Itoh H, Yodoi J, and Yokoyama M. Expression of glutaredoxin in human coronary arteries: Its potential role in antioxidant protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 1483-1487, 2001.
42. Orozco LD, Kapturczak MH, Barajas B, Wang X, Weinstein MM, Wong J, Deshane J, Bolisetty S, Shaposhinik Z, Shih DM, Agarwal A, Lusis AJ, and Araujo JA. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ Res 100: 1703-1711, 2007.
43. Orr WC and Sohal RS. Extension of life-span by over-expression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263: 1128-1130, 1994.
44. Parman T, Wiley MJ, and Wells PG. Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity. Nat Med 5: 582-585, 1999.
45. Patenaude A, Ven Murthy MR, and Mirault ME. Mitochondrial thioredoxin system: Effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J Biol Chem 279: 27302-27314, 2004.
46. Pekkari K, Avila-Carino J, Bengtsson A, Gurunath R, Scheynius A, and Holmgren A. Truncated thioredoxin (Trx80) induces production of interleukin-12 and enhances CD14 expression in human monocytes. Blood 97: 3184-3190, 2001.
47. Pekkari K, Gurunath R, Arner ES, and Holmgren A. Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma. J Biol Chem 275: 37474-37480, 2000.
48. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126, 1999.
49. Ross R, Faggiotto A, Bowen-Pope D, and Raines E. The role of endothelial injury and platelet and macrophage interactions in atherosclerosis. Circulation 70: III77-11182, 1984.
50. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
51. nd, and Liao JK. Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115: 3197-3204, 2007.
52. Schulze PC, De Keulenaer GW, Yoshioka J, Kassik KA, and Lee RT. Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin. Circ Res 91: 689-695, 2002.
53. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, and Lee RT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279: 30369-30374, 2004.
54. Shioji K, Kishimoto C, Nakamura H, Matsutani H, Yuan Z, Oka S, and Yodoi J. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxi-city. Circulation 106: 1403-1409, 2002.
55. Shioji K, Nakamura H, Masutani H, and Yodoi J. Redox regulation by thioredoxin in cardiovascular diseases. Anti-oxid Redox Signal 5: 795-802, 2003.
56. Stangel M, Zettl UK, Mix E, Zielasek J, Toyka KV, Hartung HP, and Gold R. H2O2 and nitric oxide-mediated oxidative stress induce apoptosis in rat skeletal muscle myoblasts. J Neuropathol Exp Neurol 55: 36-43, 1996.
57. Stroev SA, Gluschenko TS, Tjulkova EI, Spyrou G, Rybnikova EA, Samoilov MO, and Pelto-Hulkko M. Preconditioning enhances the expression of mitochondrial antioxidant thioredoxin-2 in the forebrain of rats exposed to severe hypobaric hypoxia. J Neurosci Res 78: 563-569, 2004.
58. Sundaresan M, Yu Z-X, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
59. Tanudji M, Hevi S, and Chuck SL. The nonclassic secretion of thioredoxin is not sensitive to redox state. Am J Physiol Cell Physiol 284: C1272-C1279, 2003.
60. Tao L, Gao E, Bryan NS, Qu Y, Liu HR, Hu A, Christopher TA, Lopez BL, Yodoi J, Koch WJ, Feelisch M, and Ma XL. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci USA 101: 11471-11476, 2004.
61. Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, and Tedgut A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation 101: 2450-2453, 2000.
62. Turoczi T, Chang VW, Engelman RM, Meulik N, Ho YS, and Das DK. Thioredoxin redox signaling in the ischemic heart: An insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 35: 695-704, 2003.
63. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, and Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98: 899-905, 1996.
64. van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Etrusalimsky JD, Quashning T, Malinski T, Gygi D, Ullrich V, and Luscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192: 1731-1744, 2000.
65. Vidavalur R, Penumathsa SV, Zhan L, Thirunavukkarasu M, and Maulik N. Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor. Vascul Pharmacol 45: 91-95, 2006.
66. Wang Y, De Keulenaer GW, and Lee RT. Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277: 26496-26500, 2002.
67. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszio A, Spitz DR, Goswami PC, Yodoi J, and Gius D. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 60: 6688-6695, 2000.
68. Wiesel P, Foster LC, Pellacani A, Layne MD, Hsieh CM, Huggins GS, Strauss P, Yet SF, and Perrella MA. Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J Biol Chem 275: 24840-24846, 2000.
69. Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, and Marsden PA. Expression of multiple isoforms of nitric oxide synthase in normal and athero-sclerotic vessels. Arterioscler Thromb Vasc Biol 17: 2479-2488, 1997.
70. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, and Sadoshima J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 112: 1395-1406, 2003.
71. Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H, and Nakashima Y. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun 271: 796-800, 2000.
72. Yamawaki H, Pan S, Lee RT, and Berk BC. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 115: 733-738, 2005.
73. Yoshida T, Maulik N, Ho YS, Alam J, and Das DK. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103: 1695-1701, 2001.
74. Yoshioka J, Schulze PC, Cupesi M, Sylvan JD, MacGIllivray C, Gannon J, Huang H, and Lee RT. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity. Circulation 2004; 109: 2581-2586, 2004.
75. Zeiher AM, Drexler H, Saurbier B, and Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92: 652-662, 1993.
76. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, Bradley J, and Min W. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94: 1483-1491, 2004
77. Zhang J, Li YD, Patel JM, and Block ER. Thioredoxin over-expression prevents NO-induced reduction of NO synthase activity in lung endothelial cells. Am J Physiol 275: L288-L293, 1998.